| Iksuda Therapeutics Ltd.. (6/7/21). "Press Release: Iksuda Therapeutics Closes $47 Million Financing Round". Newcastle. |
2021-06-07 |
| ViveBiotech S.L.. (6/4/21). "Press Release: ViveBiotech Launches Lentiviral Vector Manufacturing Plant for Cell and Gene Therapy Sector". |
2021-06-04 |
| Amyl Therapeutics. (6/3/21). "Press Release: Amyl Therapeutics Closes €18.3 Million Series A Financing to Develop Novel Therapies for Amyloidosis". Liège. |
2021-06-03 |
| Exscientia Ltd.. (6/3/21). "Press Release: Exscientia Appoints Joanne Xu, Experienced Asian Market Investor, to Board of Directors". Oxford. |
2021-06-03 |
| ImaginAb, Inc.. (6/3/21). "Press Release: ImaginAb Completes $12.8 Million Financing to Accelerate Growth Plans". Los Angeles, CA & San Diego, CA. |
2021-06-03 |
| Stablix, Inc.. (6/3/21). "Press Release: Stablix Therapeutics Launches with $63 Million Series A Financing". New York, NY. |
2021-06-03 |
| Transine Therapeutics Ltd.. (6/2/21). "Press Release: Transine Therapeutics Closes Extended Seed Funding of £9.1 Million Co-led by Takeda Ventures, Inc. and the Dementia Discovery Fund to Advance Its Novel Class of Therapeutic RNAs". Cambridge. |
2021-06-02 |
| Cytiva. (6/2/21). "Press Release: Cytiva Acquires GoSilico to Strengthen Digital Capabilities in Bioprocessing". |
2021-06-02 |
| Gilde Healthcare Partners. (6/2/21). "Press Release: Gilde Healthcare Appoints Joep Muijrers to Lead Investments in Public Markets". Utrecht. |
2021-06-02 |
| MorphoSys AG. (6/2/21). "Press Release: MorphoSys to Acquire Constellation Pharmaceuticals". Planegg & Cambridge, MA. |
2021-06-02 |
| ERS Genomics Ltd.. (6/1/21). "Press Release: Japanese Patent Office Upholds Key Charpentier/Doudna CRISPR Patent and Allows Third". Dublin. |
2021-06-01 |
| Macrophage Pharma Ltd.. (6/1/21). "Press Release: Macrophage Pharma Appoints Dr Venkat Reddy as Chief Executive Officer". Windsor. |
2021-06-01 |
| Agilent Technologies Inc.. (6/1/21). "Press Release: Agilent Presents Thought Leader Award to Professor Chris Elliott". Santa Clara, CA. |
2021-06-01 |
| Pulmocide Ltd.. (5/27/21). "Press Release: Pulmocide Raises $92 Million in a Series C Financing to Fund Registration Program for PC945". London. |
2021-05-27 |
| Coulter Partners. (5/26/21). "Press Release: Coulter Partners Secures Chief Executive Officer for Azitra". |
2021-05-26 |
| Haya Therapeutics S.A.. (5/20/21). "Press Release: Haya Therapeutics Completes CHF 18 Million Seed Financing to Advance Anti-fibrotic Therapies Targeting Long Non-Coding RNAs". Lausanne. |
2021-05-20 |
| Exscientia Ltd.. (5/19/21). "Press Release: Exscientia Announces Multi-target, AI-driven Drug Discovery Collaboration with Bristol Myers Squibb". |
2021-05-19 |
| Moderna, Inc.. (5/19/21). "Press Release: Moderna to Establish an International Business Services Hub in Warsaw, Poland. Entity Complements Six Commercial Entities in Europe". Cambridge, MA. |
2021-05-19 |
| PerkinElmer, Inc.. (5/17/21). "Press Release: PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC". Waltham, MA. |
2021-05-17 |
| ImaginAb, Inc.. (5/12/21). "Press Release: ImaginAb, Inc. Forms European Subsidiary and Appoints General Manager-Europe". Los Angeles, CA & San Diego, CA. |
2021-05-12 |
| PerkinElmer, Inc.. (5/12/21). "Press Release: PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience". Waltham, MA. |
2021-05-12 |
| BRAIN Biotech AG. (5/12/21). "Press Release: BRAIN Biotech AG Expands Stake in Successful Enzyme Producer Biocatalysts Ltd.". Zwingenberg. |
2021-05-12 |
| Abingworth LLP. (5/10/21). "Press Release: Abingworth Raises $582 Million for New Clinical Co-Development Fund – ACCD 2". London. |
2021-05-10 |
| Lonza Group AG. (5/6/21). "Press Release: Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)". Basel. |
2021-05-06 |
| TrakCel Ltd.. (5/5/21). "Press Release: TrakCel Appoints Arturo Araya as Chief Commercial Officer". Cardiff. |
2021-05-05 |
| Inivata Ltd.. (5/5/21). "Press Release: Inivata to be Acquired by NeoGenomics. Exercise of Purchase Option to Acquire Remaining Inivata Equity Interest for $390m". Research Triangle Park, NC & Cambridge. |
2021-05-05 |
| Catalym GmbH. (5/4/21). "Press Release: Catalym Appoints Industry Leader Dr. Phil L’Huillier as Chief Executive Officer". Munich. |
2021-05-04 |
| Kuur Therapeutics, Inc.. (5/4/21). "Press Release: Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform". Buffalo, NY. |
2021-05-04 |
| IP Group plc. (5/4/21). "Press Release: Portfolio Company Oxford Nanopore Technologies Raises £195m in New Investment". |
2021-05-04 |
| Osteolabs GmbH. (4/29/21). "Press Release: Osteolabs GmbH Establishes UK Presence". Kiel & Marlow. |
2021-04-29 |
| Adcendo ApS. (4/29/21). "Press Release: Adcendo Raises EUR 51 Million in Series A Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Cancers". Copenhagen. |
2021-04-29 |
| Kaia Health Software GmbH. (4/28/21). "Press Release: Kaia Health Raises $75 Million Series C to Optimize MSK and COPD Care in the U.S. and Europe". New York, NY. |
2021-04-28 |
| Inivata Ltd.. (4/28/21). "Press Release: Inivata and Agendia Sign Agreement for Commercialization of RaDaR MRD Liquid Biopsy Assay in Breast Cancer". Research Triangle Park, NC, Cambridge, Irvine, CA & Amsterdam. |
2021-04-28 |
| Exscientia Ltd.. (4/27/21). "Press Release: Exscientia Announces Investment of up to $525M". |
2021-04-27 |
| Endeavour Vision. (4/22/21). "Press Release: Endeavour Vision Closes Endeavour Medtech Growth II LP at USD 375m to Invest in Transformative Healthcare Technologies". St. Peter Port, Geneva & Minneapolis, MN. |
2021-04-22 |
| Synendos Therapeutics AG. (4/20/21). "Press Release: Synendos Therapeutics Expands Series A to CHF 24 million with New Investment". Basel. |
2021-04-20 |
| Rinri Therapeutics Ltd.. (4/20/21). "Press Release: Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss". Sheffield. |
2021-04-20 |
| Forbion Capital Partners. (4/20/21). "Press Release: Forbion Announces Final Close of Forbion Growth Opportunities Fund I at EUR 360 Million (USD 428 Million)". Naarden & Munich. |
2021-04-20 |
| Sense Biodetection Ltd.. (4/20/21). "Press Release: Sense Raises $50m Series B to Accelerate Launch of COVID-19 Molecular Test on Its Veros Instrument-free Product Platform". |
2021-04-20 |
| Mestag Therapeutics Ltd.. (4/20/21). "Press Release: Mestag Therapeutics Launches with Seed Financing of $11 Million to Develop Therapeutics Targeting Activated Fibroblast Populations across Inflammatory Disease and Cancer". Cambridge. |
2021-04-20 |
| Alchemab Therapeutics Ltd.. (4/15/21). "Press Release: Alchemab Raises £60 Million ($82 Million) in Series A Financing to Advance Novel Platform for Identifying Disease-modifying Antibody Therapeutics". Cambridge. |
2021-04-15 |
| Ori Biotech Ltd.. (4/14/21). "Press Release: ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers". London & Woodcliff Lake, NJ. |
2021-04-14 |
| Quercis Pharma AG. (4/13/21). "Press Release: Quercis Announces Executive Leadership Appointments". Zug. |
2021-04-13 |
| Congenica Ltd.. (4/13/21). "Press Release: Congenica and Camtech Diagnostics Agree Strategic Partnership to Support Genomic Analysis Expansion in Asia". Cambridge & Singapore. |
2021-04-13 |
| F2G Ltd.. (4/12/21). "Press Release: Francesco Maria Lavino Appointed Chief Executive Officer of F2G Ltd". Manchester & Vienna. |
2021-04-12 |
| Future Planet Capital Ltd.. (4/8/21). "Press Release: Future Planet Acquires One of the UK’s Oldest VC Firms". |
2021-04-08 |
| Artios Pharma Ltd.. (4/7/21). "Press Release: Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies". Cambridge & New York, NY. |
2021-04-07 |
| Congenica Ltd.. (4/6/21). "Press Release: Congenica Appoints Jayesh Pankhania as Chief Financial Officer". Cambridge. |
2021-04-06 |
| Oxford Biomedica plc. (5/6/21). "Press Release: Oxford Biomedica Signs a New Three Year Development & Supply Agreement with Boehringer Ingelheim for the Manufacture and Supply of Viral Vectors". Oxford. |
2021-04-06 |
| Achilles Therapeutics plc. (4/6/21). "Press Release: Achilles Therapeutics Announces Closing of $175.5 Million Initial Public Offering". London. |
2021-04-06 |
| Metrion Biosciences Ltd.. (4/6/21). "Press Release: Metrion Biosciences Closes £2.7m New Equity Financing. Financing Led by Gresham House Ventures". Cambridge. |
2021-04-06 |
| Valneva S.E.. (4/6/21). "Press Release: Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001". Saint-Herblain. |
2021-04-06 |
| Promega Corporation. (4/1/21). "Press Release: New General Manager at Promega GmbH. Hans-Joachim Müller Takes Over Business from April 1, 2021". Walldorf. |
2021-04-01 |
| Pyxis Oncology. (3/30/21). "Press Release: Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics". Cambridge, MA. |
2021-03-30 |
| Achilles Therapeutics plc. (3/30/21). "Press Release: Achilles Therapeutics Announces Pricing of Initial Public Offering". London. |
2021-03-30 |
| Inbrain Neuroelectronics S.L.. (3/26/21). "Press Release: Inbrain Neuroelectronics Raises Over €14M Series A". Barcelona. |
2021-03-26 |
| Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing". London. |
2021-03-26 |
| Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces Additional Financing Plans". London. |
2021-03-26 |
| Eliem Therapeutics, Inc.. (3/25/21). "Press Release: Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders". Seattle, WA & Cambrigde. |
2021-03-25 |
| Merck & Co., Inc.. (3/24/21). "Press Release: Merck Appoints Caroline Litchfield Chief Financial Officer". Kenilworth, NJ. |
2021-03-24 |
| Arix Bioscience plc. (3/24/21). "Press Release: Strategy Implementation Review". London. |
2021-03-24 |
| Dunad Therapeutics. (3/23/21). "Press Release: Dunad Therapeutics Emerges to Develop Next-generation Small Molecule Therapeutics Based on First Tuneable Targeted Protein Degradation Technology". Cambridge. |
2021-03-23 |
| PhoreMost Ltd.. (3/23/21). "Press Release: PhoreMost Closes £33M ($46M) Series B Financing". Cambridge. |
2021-03-23 |
| Auro Biosciences, Inc.. (3/22/21). "Press Release: Aura Biosciences Announces Oversubscribed $80 Million Financing". Cambridge, MA. |
2021-03-22 |
| Dotmatics Ltd.. (3/22/21). "Press Release: Insightful Science Joins Forces with Dotmatics to Form a Leading Cloud-First Scientific R&D Company". Bishop’s Stortford & San Diego, CA. |
2021-03-22 |
| Aber Instruments. (3/22/21). "Press Release: Aber Introduces Futura neotf On-line Single-use Biomass Sensor". Aberystwyth. |
2021-03-22 |
| Elicera Therapeutics AB. (3/22/21). "Press Release: Elicera Announces Appointment of ATMP Specialist Karin Hoogendoorn to the Board". Gothenburg. |
2021-03-22 |
| Life Sciences Partners (LSP). (3/18/21). "Press Release: LSP Announces Closing of Upsized $120 Million Nasdaq IPO of European Biotech Acquisition Corp (EBAC) Targeting European Biotech". Amsterdam. |
2021-03-18 |
| Selexis S.A.. (3/18/21). "Press Release: SpyBiotech Licenses Selexis Best-in-Class Cell Line Development Technologies to Advance Human Cytomegalovirus VLP Vaccine Program". Geneva. |
2021-03-18 |
| Alligator Bioscience AB. (3/18/21). "Press Release: Alligator Bioscience Appoints Søren Bregenholt as New CEO". Lund. |
2021-03-18 |
| Vaccitech Ltd.. (3/17/21). "Press Release: Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results". Oxford. |
2021-03-17 |
| Amphista Therapeutics Ltd.. (3/17/21). "Press Release: Amphista Therapeutics Raises $53M in Oversubscribed Series B Round to Advance Next Generation Targeted Protein Degradation Assets". Glasgow. |
2021-03-17 |
| Axol Bioscience Ltd.. (3/17/21). "Press Release: Axol Bioscience and Censo Biotechnologies Announce Merger". Cambridge. |
2021-03-17 |
| CytoSeek Ltd.. (3/16/21). "Press Release: CytoSeek Raises £3.57M ($5M) to Advance Its Mission to Develop the Next Generation of Cell Therapies for Cancer". Bristol. |
2021-03-16 |
| Alchemab Therapeutics Ltd.. (3/16/21). "Press Release: Alchemab and Medicines Discovery Catapult to Develop Landmark Novel Antibody Therapy for Huntington’s disease". London. |
2021-03-16 |
| Antiverse Ltd.. (3/15/21). "Press Release: Antiverse Raises £1.4 Million ($2 Million USD) to Advance Its AI Antibody Drug Discovery Platform". |
2021-03-15 |
| Touchlight Genetics Ltd.. (3/11/21). "Press Release: Touchlight Raises £42 Million ($58 Million) to Meet Unprecedented Global DNA Demand". Hampton. |
2021-03-11 |
| Inivata Ltd.. (3/9/21). "Press Release: FDA Grants Breakthrough Device Designation for Inivata’s RaDaR Assay". Research Triangle Park, NC & Cambridge. |
2021-03-09 |
| Pathios Therapeutics Ltd.. (3/8/21). "Press Release: Pathios Therapeutics Boosted by Award of Significant Innovate UK Funding". Oxford. |
2021-03-08 |
| Exscientia Ltd.. (3/4/21). "Press Release: Exscientia Completes $100 Million Series C Financing Round with BlackRock Funds". |
2021-03-04 |
| Autifony Therapeutics Ltd.. (3/4/21). "Press Release: Autifony Therapeutics, Boehringer Ingelheim to Collaborate On Novel Ion Channel Target with Potential in Multiple Disease Areas Related to Lysosomal Storage Disorders". Stevenage. |
2021-03-04 |
| Sofinnova Partners. (3/3/21). "Press Release: Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-stage Healthcare Crossover Fund". Paris. |
2021-03-03 |
| TrakCel Ltd.. (3/3/21). "Press Release: TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round". Cardiff. |
2021-03-03 |
| LGC. (3/3/21). "Press Release: LGC Acquires Paragon Scientific, Strengthening Its Position in Reference Materials". London. |
2021-03-03 |
| Dotmatics Ltd.. (3/3/21). "Press Release: Dotmatics Announces Licensing Agreement for Informatics Software with Compugen". Bishop’s Stortford. |
2021-03-03 |
| ERS Genomics Ltd.. (3/3/21). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical". Dublin. |
2021-03-03 |
| Osborne Clarke. (3/2/21). "Press Release: Osborne Clarke Advises Oxular on Its £27M Financing". |
2021-03-02 |
| Oxford Genetics Ltd.. (3/2/21). "Press Release: WuXi AppTec Completes Acquisition of Oxgene to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers". Philadeliphia, PA & Oxford. |
2021-03-02 |
| Shorla Pharma Ltd.. (3/2/21). "Press Release: Shorla Pharma Announces U.S. Industry Veteran Nicholas Holsman as Chief Commercial Officer". Clonmel. |
2021-03-02 |
| Gyroscope Therapeutics Ltd.. (3/1/21). "Press Release: Gyroscope Therapeutics Appoints Jessica Stitt as Chief Financial Officer". London. |
2021-03-01 |
| Achilles Therapeutics plc. (3/1/21). "Press Release: Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States". London. |
2021-03-01 |
| Oxular Ltd.. (3/1/21). "Press Release: Oxular Raises $37 Million". Oxford. |
2021-03-01 |
| Congenica Ltd.. (3/1/21). "Press Release: Congenica Appoints Kamraan Shariff as Chief Business Development Officer". Cambridge. |
2021-03-01 |
| ERS Genomics Ltd.. (3/1/21). "Press Release: ERS Genomics Expands Team With Appointment of Jon Kratochvil as VP Business Development". Dublin. |
2021-03-01 |
| Leukocare AG. (3/1/21). "Press Release: Leukocare and Malvern Collaborate on Stabilization and Formulation Development of COVID-19 Vaccines". Martinsried & Malvern. |
2021-03-01 |
| Nabriva Therapeutics plc. (2/26/21). "Press Release: Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer". Dublin & King of Prussia, PA. |
2021-02-26 |
| Coulter Partners. (2/25/21). "Press Release: Coulter Partners Announces New Appointments in London, the US and Germany". |
2021-02-25 |
| Orna Therapeutics. (2/24/21). "Press Release: Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies". Cambridge, MA. |
2021-02-24 |
| Aptum Biologics Ltd.. (2/24/21). "Press Release: New Features of EpiQuest Suite Software (v4)". Southampton. |
2021-02-24 |
| Newcells Biotech Ltd.. (2/23/21). "Press Release: Newcells Biotech Secures Over £5m for 3D Tissue Models". |
2021-02-23 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo-2019.png){kind=logo}
![Picture [iito] Made Without Love 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-made-without-love.jpg)
Date
![Picture [iito] Back into Ad 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-back-into-ad.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
